We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
NBT Bancorp
NBTB
$2.73B
| $301K | ﹤0.01% |
7,871
+107
| +1% | +$4.26K |
|
877
Tapestry
TPR
$29.8B
| $299K | ﹤0.01% |
5,971
-66,674
| -92% | -$3.26M |
|
878
Liberty Broadband Class C
LBRDK
$4.44B
| $297K | ﹤0.01% |
3,529
-568
| -14% | -$45.3K |
|
|
HSBC.PRA
879
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $295K | ﹤0.01% |
11,525
-7,600
| -40% | -$198K |
|
880
Globus Medical
GMED
$10.6B
| $294K | ﹤0.01% |
5,187
+1,862
| +56% | +$98K |
|
|
ALXN
881
DELISTED
Alexion Pharmaceuticals
ALXN
| $294K | ﹤0.01% |
2,120
-9,739
| -82% | -$1.22M |
|
882
Innovative Industrial Properties
IIPR
$1.78B
| $289K | ﹤0.01% |
6,000
+4,000
| +200% | +$153K |
|
883
Aptiv
APTV
$12.2B
| $287K | ﹤0.01% |
3,439
-109
| -3% | -$9.96K |
|
884
SouthState Bank Corp
SSB
$10.2B
| $287K | ﹤0.01% |
3,508
+1,313
| +60% | +$111K |
|
885
Spotify
SPOT
$102B
| $285K | ﹤0.01% |
1,584
+10
| +0.6% | +$1.83K |
|
886
Vodafone
VOD
$36.4B
| $284K | ﹤0.01% |
13,094
+511
| +4% | +$11.9K |
|
|
DCM
887
DELISTED
NTT DOCOMO, Inc.
DCM
| $284K | ﹤0.01% |
10,578
+2,452
| +30% | +$65.8K |
|
|
MZTI
888
The Marzetti Company
MZTI
$2.95B
| $282K | ﹤0.01% |
1,895
| – | – |
|
889
Neogen
NEOG
$2.03B
| $282K | ﹤0.01% |
7,936
-354
| -4% | -$15.1K |
|
890
Gen Digital
GEN
$16.1B
| $278K | ﹤0.01% |
13,098
-5,257
| -29% | -$107K |
|
891
Steven Madden
SHOO
$3.18B
| $278K | ﹤0.01% |
7,898
+668
| +9% | +$24.8K |
|
|
NBL
892
DELISTED
Noble Energy, Inc.
NBL
| $277K | ﹤0.01% |
8,928
-184
| -2% | -$5.89K |
|
893
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
| $275K | ﹤0.01% |
7,190
+1,748
| +32% | +$68.3K |
|
894
Fluor
FLR
$7.22B
| $274K | ﹤0.01% |
4,732
+7
| +0.1% | +$381 |
|
895
NXP Semiconductors
NXPI
$67.6B
| $274K | ﹤0.01% |
3,223
+2,156
| +202% | +$207K |
|
896
Vornado Realty Trust
VNO
$7.43B
| $274K | ﹤0.01% |
3,766
+66
| +2% | +$4.89K |
|
|
WBT
897
DELISTED
Welbilt, Inc.
WBT
| $272K | ﹤0.01% |
13,065
+4,695
| +56% | +$103K |
|
898
Thomson Reuters
TRI
$42.7B
| $270K | ﹤0.01% |
5,102
+2,948
| +137% | +$148K |
|
899
Antero Midstream
AM
$10.4B
| $269K | ﹤0.01% |
15,925
+11,950
| +301% | +$219K |
|
|
BAC.WS.A
900
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $267K | ﹤0.01% |
+15,000
| New | +$281K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.